BMJ 2001;323:13 ( 7 July )

Papers

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

Fiona A Campbell, consultant in anaesthetics and pain management, ^a Martin R Tramèr, staff anaesthetist, ^b Dawn Carroll, senior research nurse, ^c D John M Reynolds, consultant clinical pharmacologist, ^d R Andrew Moore, consultant biochemist, ^c Henry J McQuay, professor of pain relief. ^c

^a Pain Management Centre, Undercroft, South Block, Queen's Medical Centre, Nottingham NG7 2UH, ^b Division d'Anesthésiologie, Département APSIC, Höpitaux Universitaires, CH-1211 Genève 14, Switzerland, ^c Pain Research, Nuffield Department of Anaesthetics, The Churchill, Oxford Radcliffe Hospital, Oxford OX3 7LJ, ^d Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford OX2 6HE

Correspondence to: F A Campbell fiona.campbell{at}mail.qmcuh-tr.trent.nhs.uk

Objective: To establish whether cannabis is an effective and safe treatment option in the management of pain.
Design: Systematic review of randomised controlled trials.
Data sources: Electronic databases Medline, Embase, Oxford Pain Database, and Cochrane Library; references from identified papers; hand searches.
Study selection: Trials of cannabis given by any route of administration (experimental intervention) with any analgesic or placebo (control intervention) in patients with acute, chronic non-malignant, or cancer pain. Outcomes examined were pain intensity scores, pain relief scores, and adverse effects. Validity of trials was assessed independently with the Oxford score.
Data extraction: Independent data extraction; discrepancies resolved by consensus.
Data synthesis: 20 randomised controlled trials were identified, 11 of which were excluded. Of the 9 included trials (222 patients), 5 trials related to cancer pain, 2 to chronic non-malignant pain, and 2 to acute postoperative pain. No randomised controlled trials evaluated cannabis; all tested active substances were cannabinoids. Oral delta-9-tetrahydrocannabinol (THC) 5-20 mg, an oral synthetic nitrogen analogue of THC 1 mg, and intramuscular levonantradol 1.5-3 mg were about as effective as codeine 50-120 mg, and oral benzopyranoperidine 2-4 mg was less effective than codeine 60-120 mg and no better than placebo. Adverse effects, most often psychotropic, were common.
Conclusion: Cannabinoids are no more effective than codeine in controlling pain and have depressant effects on the central nervous system that limit their use. Their widespread introduction into clinical practice for pain management is therefore undesirable. In acute postoperative pain they should not be used. Before cannabinoids can be considered for treating spasticity and neuropathic pain, further valid randomised controlled studies are needed.

What is already known on this topic Three quarters of British doctors surveyed in 1994 wanted cannabis available on prescription Humans have cannabinoid receptors in the central and peripheral nervous system In animal testing cannabinoids are analgesic and reduce signs of neuropathic pain Some evidence exists that cannabinoids may be analgesic in humans What this study adds No studies have been conducted on smoked cannabis Cannabinoids give about the same level of pain relief as codeine in acute postoperative pain They depress the central nervous system

---

© BMJ 2001

Related Articles

Cannabinoids for chronic pain

Steven P Cohen
BMJ 2008 336: 167-168. [Extract] [Full Text] [PDF]

Cannabinoids in pain management

Ethan Russo, Leslie Iversen, Denis J Petro, Franjo Grotenhermen, Fiona A Campbell, Andrew Moore, Henry J McQuay, Dawn Carroll, Martin R Tramèr, and D John M Reynolds
BMJ 2001 323: 1249. [Extract] [Full Text]

Canada legalises the medical use of cannabis

David Spurgeon
BMJ 2001 323: 68. [Extract] [Full Text]

Cannaboids are effective as analgesics and antiemetics but have side effects
BMJ 2001 323: 0. [Full Text]

Cannabinoids for pain and nausea

Eija Kalso
BMJ 2001 323: 2-3. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Frank, B, Serpell, M G, Hughes, J, Matthews, J N S, Kapur, D (2008). Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study. BMJ 336: 199-201 [Abstract] [Full text]  
• Cohen, S. P (2008). Cannabinoids for chronic pain. BMJ 336: 167-168 [Full text]  
• Esfandyari, T., Camilleri, M., Busciglio, I., Burton, D., Baxter, K., Zinsmeister, A. R. (2007). Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G137-G145 [Abstract] [Full text]  
• Chong, M S, Wolff, K, Wise, K, Tanton, C, Winstock, A, Silber, E (2006). Cannabis use in patients with multiple sclerosis. Mult Scler 12: 646-651 [Abstract]  
• Pacher, P., Batkai, S., Kunos, G. (2006). The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacol. Rev. 58: 389-462 [Abstract] [Full text]  
• Hung, O., Lynch, M. E., Clark, A. J. (2006). Cannabinoids and pain management/Les cannabinoides et le controle de la douleur.. Canadian J. Anesthesia 53: 743-746 [Full text]  
• Beaulieu, P. (2006). Effects of nabilone, a synthetic cannabinoid, on postoperative pain: [Les effets de la nabilone, un cannabinoide synthetique, sur la douleur postoperatoire].. Canadian J. Anesthesia 53: 769-775 [Abstract] [Full text]  
• Burns, T. L, Ineck, J. R (2006). Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain. The Annals of Pharmacotherapy 40: 251-260 [Abstract] [Full text]  
• White, P. F. (2005). The Changing Role of Non-Opioid Analgesic Techniques in the Management of Postoperative Pain. Anesth. Analg. 101: S5-22 [Abstract] [Full text]  
• Rog, D. J., Nurmikko, T. J., Friede, T., Young, C. A. (2005). Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 65: 812-819 [Abstract] [Full text]  
• de Jong, F. A., Engels, F. K., Mathijssen, R. H.J., van Zuylen, L., Verweij, J., Peters, R. P.H., Sparreboom, A. (2005). Medicinal Cannabis in Oncology Practice: Still a Bridge Too Far?. JCO 23: 2886-2891 [Full text]  
• Woodward, K N (2005). The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products. Hum Exp Toxicol 24: 219-233 [Abstract]  
• Lam, P. M. W., McDonald, J., Lambert, D. G. (2005). Characterization and comparison of recombinant human and rat TRPV1 receptors: effects of exo- and endocannabinoids. Br J Anaesth 94: 649-656 [Abstract] [Full text]  
• Deusch, E., Kress, H. G., Kraft, B., Kozek-Langenecker, S. A. (2004). The Procoagulatory Effects of Delta-9-Tetrahydrocannabinol in Human Platelets. Anesth. Analg. 99: 1127-1130 [Abstract] [Full text]  
• Lussier, D., Huskey, A. G., Portenoy, R. K. (2004). Adjuvant Analgesics in Cancer Pain Management. The Oncologist 9: 571-591 [Abstract] [Full text]  
• Wade, D. T, Makela, P., Robson, P., House, H., Bateman, C. (2004). Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler 10: 434-441 [Abstract]  
• Hayry, M (2004). Prescribing cannabis: freedom, autonomy, and values. J. Med. Ethics 30: 333-336 [Abstract] [Full text]  
• Svendsen, K. B, Jensen, T. S, Bach, F. W (2004). Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 329: 253- [Abstract] [Full text]  
• Hall, E J, Sykes, N P (2004). Analgesia for patients with advanced disease: 2. Postgrad. Med. J. 80: 190-195 [Abstract] [Full text]  
• Karst, M., Salim, K., Burstein, S., Conrad, I., Hoy, L., Schneider, U. (2003). Analgesic Effect of the Synthetic Cannabinoid CT-3 on Chronic Neuropathic Pain: A Randomized Controlled Trial. JAMA 290: 1757-1762 [Abstract] [Full text]  
• Iversen, L. (2003). Cannabis and the brain. Brain 126: 1252-1270 [Abstract] [Full text]  
• (2003). OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02). Evid. Based Nurs. 6: e1-1 [Full text]  
• Wade, D. T, Robson, P., House, H., Makela, P., Aram, J. (2003). A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil 17: 21-29 [Abstract]  
• Kinzbrunner, B. M (2002). Review: cannabinoids and codeine have similar effects on pain relief, but cannabinoids commonly cause psychotropic adverse effects. Evid. Based Med. 7: 24-24 [Full text]  
• Russo, E., Iversen, L., Petro, D. J, Grotenhermen, F., Campbell, F. A, Moore, A., McQuay, H. J, Carroll, D., Tramer, M. R, Reynolds, D J. M (2001). Cannabinoids in pain management. BMJ 323: 1249-1249 [Full text]  
• (2001). Efficacy and Safety of Cannabinoids for Pain Management. JWatch Neurology 2001: 8-8 [Full text]  
• (2001). Medical Marijuana: Should We Recommend It for Pain and Nausea?. JWatch Emergency Med. 2001: 14-14 [Full text]  
• (2001). Cannabinoids for Pain and Nausea: They Work, but There's a Price. JWatch General 2001: 7-7 [Full text]  
• Kalso, E. (2001). Cannabinoids for pain and nausea. BMJ 323: 2-3 [Full text]  

Rapid Responses:

Read all Rapid Responses

Cannabanoids and pain

Julian Abel
bmj.com, 6 Jul 2001 [Full text]

Hospital vs. Personal Therapy

Ned Hoke
bmj.com, 9 Jul 2001 [Full text]

Cannabinoids for pain treatment: more clinical trials needed

Pierre Beaulieu
bmj.com, 9 Jul 2001 [Full text]

More Research Needed

William Notcutt
bmj.com, 10 Jul 2001 [Full text]

Spasticity is distinct from pain

Denis J Petro
bmj.com, 14 Jul 2001 [Full text]

Can we make a good omelette from rotten eggs?

M S Chong, et al.
bmj.com, 17 Jul 2001 [Full text]

A review of nothing is not worth anything

Leslie Iversen
bmj.com, 23 Jul 2001 [Full text]

Therapeutic Potential of Cannabinoids

Petra Makela
bmj.com, 25 Jul 2001 [Full text]

Cannabinoid and Pain

Magdi Hanna
bmj.com, 31 Jul 2001 [Full text]

Cannabis and pain - looking through the smoke

D Kapur
bmj.com, 1 Aug 2001 [Full text]

Cannabinoids are not cannabis

Willem K Scholten
bmj.com, 22 Sep 2001 [Full text]